Role of zonisamide in advanced Parkinson’s disease: a randomized placebo-controlled study

被引：0
|
作者：
Mohamed Essam
Eman Hamid
Eman Abushady
Mahmoud El-Balkimy
Angelo Antonini
Ali Shalash
机构：
[1] Ain Shams University,Department of Neurology, Faculty of Medicine
[2] University of Padua,Parkinson and Movement Disorders Unit, Study Center for Neurodegeneration (CESNE), Department of Neuroscience
来源：
Neurological Sciences | 2024年 / 45卷
关键词：
Zonisamide; Parkinson̕ s disease; Wearing off; Nonmotor symptoms; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1725 / 1734
页数：9
相关论文
共 50 条
  • [21] Mucuna pruriens in parkinson's disease: a double-blind, randomized, placebo-controlled, crossover study
    Cilia, R.
    Laguna, J.
    Cassani, E.
    Cereda, E.
    Pezzoli, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E262 - E263
  • [22] Helicobacter pylori eradication in Parkinson's disease: A double-blind randomized placebo-controlled study
    Tan, A. H.
    Lim, S. Y.
    Mahadeva, S.
    Loke, M. F.
    Vadivelu, J. S.
    Marras, C.
    Fox, H.
    Lang, A. E.
    MOVEMENT DISORDERS, 2020, 35 : S422 - S425
  • [23] Atomoxetine for the Treatment of Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
    Weintraub, Daniel
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A67 - A67
  • [24] Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease
    Putt, ME
    Ravina, B
    CONTROLLED CLINICAL TRIALS, 2002, 23 (02): : 111 - 126
  • [25] A randomized, double-blind, placebo-controlled study of atornoxetine for freezing of gait in Parkinson's disease
    Nashatizadeh, M. M.
    Jimenez, J. E.
    Davidson, A. L.
    Jankovic, J.
    MOVEMENT DISORDERS, 2008, 23 (01) : S219 - S219
  • [26] Atomoxetine for the treatment of depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Weintraub, D.
    Mavandadi, S.
    Horn, S.
    Hurtig, H.
    Siderowf, A.
    Duda, J.
    Stern, M.
    MOVEMENT DISORDERS, 2009, 24 : S286 - S286
  • [27] Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
    Zhang, Zhen-Xin
    Liu, Chun-Feng
    Tao, En-Xiang
    Shao, Ming
    Liu, Yi-Ming
    Wang, Jian
    Asgharnejad, Mahnaz
    Xue, Hai-Bo
    Surmann, Erwin
    Bauer, Lars
    PARKINSONISM & RELATED DISORDERS, 2017, 44 : 6 - 12
  • [28] Rapid efficacy of a noradrenergic reuptake inhibitor in depression in advanced Parkinson's disease:: A double-blind, randomized, placebo-controlled study
    Devos, D.
    Poirot, I.
    Dujardin, K.
    Duhem, S.
    Lucas, B.
    Waucquier, N.
    Moreau, C.
    Bocquillon, P.
    Devos, P.
    Ajebbar, K.
    Thielemans, B.
    Cottencin, O.
    Thomas, P.
    Destee, A.
    Bordet, R.
    Defebvre, L.
    MOVEMENT DISORDERS, 2007, 22 : S223 - S224
  • [29] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [30] A placebo-controlled study of memantine in advanced Alzheimer's disease.
    Reisberg, B
    Stoeffler, A
    Ferris, S
    Schmitt, F
    Doody, R
    Moebuis, HJ
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (02): : 90 - 90
12345